Cardiovascular Engineering (CVE) is an innovative medtech start-up dedicated to developing next-generation artificial heart technologies. Focused on minimally invasive and fully implantable solutions for advanced heart failure, CVE combines cutting-edge engineering with clinical expertise to save and improve patients lives. The company is seeking strategic medical technology, research and investment partners to accelerate product development, clinical validation and global impact in life-saving cardiac care.
1) Innovation Ecosystem
Business Breakfast & Matchmaking;
Economic Mission to Moldova Digital Summit 2025 (International Tech Synergy);
Digital Feasibility Study (DFS) – technical expertise report, technological feasibility and innovation; TRL assessment and target level identification of the system.
3) Access to Finance
Grant Readiness – support for accessing non-reimbursable financing; responses to POC clarifications;